{"context":{"query":">>efo>>gwas_study","source_dataset":"efo","target_dataset":"gwas_study"},"stats":{"queried":1,"total":68,"mapped":1},"pagination":{"has_next":false},"schema":"id|disease_trait|first_author|journal|publication_date","mappings":[{"input":"EFO:0000474","source":"EFO:0000474|epilepsy","targets":["GCST001329|Epilepsy|Guo Y|Hum Mol Genet|2011-11-24","GCST001662|Generalized epilepsy|EPICURE Consortium|Hum Mol Genet|2012-09-04","GCST002141|Epilepsy (remission after treatment)|Speed D|Hum Mol Genet|2013-08-19","GCST002547|Epilepsy|Anney RJ|Lancet Neurol|2014-07-30","GCST002949|Epilepsy and lamotrigine-induced maculopapular eruptions|Jang HW|Epilepsy Res|2015-06-02","GCST002950|Epilepsy|Jang HW|Epilepsy Res|2015-06-02","GCST007343|Epilepsy|International League Against Epilepsy Consortium on Complex Epilepsies|Nat Commun|2018-12-10","GCST012370|Epilepsy|Suzuki T|Epilepsia|2021-04-29","GCST90013712|Epilepsy|Ishigaki K|Nat Genet|2020-06-08","GCST90013748|Epilepsy|Ishigaki K|Nat Genet|2020-06-08","GCST90013783|Epilepsy|Ishigaki K|Nat Genet|2020-06-08","GCST90013895|Epilepsy (Firth correction)|Mbatchou J|Nat Genet|2021-05-20","GCST90013945|Epilepsy (SPA correction)|Mbatchou J|Nat Genet|2021-05-20","GCST90018620|Epilepsy|Sakaue S|Nat Genet|2021-09-30","GCST90018840|Epilepsy|Sakaue S|Nat Genet|2021-09-30","GCST90027898|Epilepsy|Song M|Front Neurosci|2021-08-12","GCST90038645|Epilepsy|Donertas HM|Nat Aging|2021-04-08","GCST90043755|Epilepsy (PheCode 345.1)|Jiang L|Nat Genet|2021-11-04","GCST90077743|Epilepsy|Backman JD|Nature|2021-10-18","GCST90077744|ICD10 G40: epilepsy|Backman JD|Nature|2021-10-18","GCST90079823|ICD10 G40.3: Generalized idiopathic epilepsy and epileptic syndromes|Backman JD|Nature|2021-10-18","GCST90079824|ICD10 G40.9: Epilepsy, unspecified|Backman JD|Nature|2021-10-18","GCST90079825|ICD10 G40: Epilepsy and recurrent seizures|Backman JD|Nature|2021-10-18","GCST90081729|Epilepsy (Gene-based burden)|Backman JD|Nature|2021-10-18","GCST90081730|ICD10 G40: epilepsy (Gene-based burden)|Backman JD|Nature|2021-10-18","GCST90083809|ICD10 G40.3: Generalized idiopathic epilepsy and epileptic syndromes (Gene-based burden)|Backman JD|Nature|2021-10-18","GCST90083810|ICD10 G40.9: Epilepsy, unspecified (Gene-based burden)|Backman JD|Nature|2021-10-18","GCST90083811|ICD10 G40: Epilepsy and recurrent seizures (Gene-based burden)|Backman JD|Nature|2021-10-18","GCST90239783|Seizures in pediatric ALL|Anastasopoulou S|Haematologica|2022-03-31","GCST90246064|ICD10 G40: epilepsy|Walters RG|Cell Genom|2023-07-20","GCST90271608|Epilepsy|International League Against Epilepsy Consortium on Complex Epilepsies|Nat Genet|2023-08-31","GCST90271611|Epilepsy|International League Against Epilepsy Consortium on Complex Epilepsies|Nat Genet|2023-08-31","GCST90281287|Genetic generalized epilepsy or focal epilepsy (pleiotropy)|International League Against Epilepsy Consortium on Complex Epilepsies|Nat Genet|2023-08-31","GCST90281291|Epilepsy|International League Against Epilepsy Consortium on Complex Epilepsies|Nat Genet|2023-08-31","GCST90297579|ICD10 G40: epilepsy (CNV mirror model)|Auwerx C|Genome Med|2024-01-08","GCST90297633|ICD10 G40: epilepsy (CNV U-shape model)|Auwerx C|Genome Med|2024-01-08","GCST90297686|ICD10 G40: epilepsy (CNV duplication-only model)|Auwerx C|Genome Med|2024-01-08","GCST90297730|ICD10 G40: epilepsy (CNV deletion-only model)|Auwerx C|Genome Med|2024-01-08","GCST90435926|Epilepsy, recurrent seizures, convulsions (PheCode 345)|Zhou W|Nat Genet|2018-08-13","GCST90435927|Epilepsy (PheCode 345.1)|Zhou W|Nat Genet|2018-08-13","GCST90435928|Generalized convulsive epilepsy (PheCode 345.11)|Zhou W|Nat Genet|2018-08-13","GCST90435930|Convulsions (PheCode 345.3)|Zhou W|Nat Genet|2018-08-13","GCST90473322|ICD10 G40: epilepsy|UK Biobank Whole-Genome Sequencing Consortium|Nature|2025-08-06","GCST90476929|Epilepsy / seizure disorder|Verma A|Science|2024-07-19","GCST90476930|Epilepsy / seizure disorder|Verma A|Science|2024-07-19","GCST90476931|Epilepsy / seizure disorder|Verma A|Science|2024-07-19","GCST90476932|Takes medication for epilepsy/seizure disorder?|Verma A|Science|2024-07-19","GCST90476933|Takes medication for epilepsy/seizure disorder?|Verma A|Science|2024-07-19","GCST90477549|Epilepsy, recurrent seizures, convulsions (PheCode 345)|Verma A|Science|2024-07-19","GCST90477550|Epilepsy, recurrent seizures, convulsions (PheCode 345)|Verma A|Science|2024-07-19","GCST90477551|Epilepsy, recurrent seizures, convulsions (PheCode 345)|Verma A|Science|2024-07-19","GCST90477552|Epilepsy (PheCode 345.1)|Verma A|Science|2024-07-19","GCST90477553|Epilepsy (PheCode 345.1)|Verma A|Science|2024-07-19","GCST90477554|Epilepsy (PheCode 345.1)|Verma A|Science|2024-07-19","GCST90477555|Generalized convulsive epilepsy (PheCode 345.11)|Verma A|Science|2024-07-19","GCST90477558|Convulsions (PheCode 345.3)|Verma A|Science|2024-07-19","GCST90477559|Convulsions (PheCode 345.3)|Verma A|Science|2024-07-19","GCST90477560|Convulsions (PheCode 345.3)|Verma A|Science|2024-07-19","GCST90480020|Generalized convulsive epilepsy (PheCode 345.11)|Verma A|Science|2024-07-19","GCST90481047|Epilepsy (PheCode 345.1)|Verma A|Science|2024-07-19","GCST90481056|Convulsions (PheCode 345.3)|Verma A|Science|2024-07-19","GCST90481057|Epilepsy, recurrent seizures, convulsions (PheCode 345)|Verma A|Science|2024-07-19","GCST90481167|Epilepsy / seizure disorder|Verma A|Science|2024-07-19","GCST90481194|Takes medication for epilepsy/seizure disorder?|Verma A|Science|2024-07-19","GCST90481392|Takes medication for epilepsy/seizure disorder?|Verma A|Science|2024-07-19","GCST90481875|Generalized convulsive epilepsy (PheCode 345.11)|Verma A|Science|2024-07-19","GCST90651628|Epilepsy (PheCode 345.1)|Liu TY|Sci Adv|2025-06-04","GCST90652019|Epilepsy, recurrent seizures, convulsions (PheCode 345)|Liu TY|Sci Adv|2025-06-04"]}]}